Patients and science are at the center of everything we do at Sanofi.
This is reflected in our relationships and work with US patient advocacy groups. Sanofi recognizes and respects the vital and tireless work that patient advocacy groups perform every day on behalf of the patients and families they serve. We engage with the patient advocacy community to listen to their perspectives, understand what matters most to patients, and champion these patient-centric insights internally and externally.
Partnering on Shared Goals Focused on the Needs of Patients
We engage with patient advocacy groups from early research throughout the lifecycle of Sanofi medicines and vaccines. Partnerships work to achieve shared goals with the US patient advocacy community that are focused on patients:
Principles That Define Our Approach with Patient Advocacy Groups
How we partner is driven by:
- Truly listening
- Open, honest dialogue
- Mutual respect
- Collaboration and partnerships
- Non-promotional communications
- Transparency
- Highest standard of ethics and integrity
Working with the Advocacy Community
We Won’t Give Up: Advocating for the Rare Disease Community
Sponsorships and Contributions
Sanofi supports specific activities and initiatives of US patient advocacy groups that are focused on improving patient care. Sponsorship requests are submitted through applications completed on our online portals to be evaluated by an internal committee.
Corporate Giving & Support – Sanofi US
Contributions & Giving – Sanofi Genzyme
Transparency
Patient Access and Affordability
Sanofi has multiple programs and resources to support patients with access and affordability for their medications and to provide assistance to those with specific needs.
Clinical Trials
Other Helpful Links
Managed Access Programs (MAPs)
